JPH08512322A - Ｈ▲下２▼拮抗剤−胃腸運動性の薬剤組合せ物 - Google Patents

Ｈ▲下２▼拮抗剤−胃腸運動性の薬剤組合せ物

Info

Publication number
JPH08512322A
JPH08512322A JP7504109A JP50410994A JPH08512322A JP H08512322 A JPH08512322 A JP H08512322A JP 7504109 A JP7504109 A JP 7504109A JP 50410994 A JP50410994 A JP 50410994A JP H08512322 A JPH08512322 A JP H08512322A
Authority
JP
Japan
Prior art keywords
cisapride
gastrointestinal
pharmaceutically acceptable
famotidine
stereoisomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7504109A
Other languages
English (en)
Japanese (ja)
Inventor
シムズ，ロバート・テイ
スリブカ，ウイリアム
Original Assignee
メルク エンド カンパニー インコーポレーテッド
マクニール−ピー・ピー・シー・インコーポレイテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メルク エンド カンパニー インコーポレーテッド, マクニール−ピー・ピー・シー・インコーポレイテツド filed Critical メルク エンド カンパニー インコーポレーテッド
Publication of JPH08512322A publication Critical patent/JPH08512322A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP7504109A 1993-07-06 1994-07-05 Ｈ▲下２▼拮抗剤−胃腸運動性の薬剤組合せ物 Pending JPH08512322A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8759093A 1993-07-06 1993-07-06
US087.590 1993-07-06
PCT/US1994/007520 WO1995001803A1 (fr) 1993-07-06 1994-07-05 Combinaisons d'agents anti-h2 et d'agents de motilite gastro-intestinale

Publications (1)

Publication Number Publication Date
JPH08512322A true JPH08512322A (ja) 1996-12-24

Family

ID=22206098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7504109A Pending JPH08512322A (ja) 1993-07-06 1994-07-05 Ｈ▲下２▼拮抗剤−胃腸運動性の薬剤組合せ物

Country Status (5)

Country Link
EP (1) EP0707492A1 (fr)
JP (1) JPH08512322A (fr)
AU (1) AU7397194A (fr)
CA (1) CA2166730A1 (fr)
WO (1) WO1995001803A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013542985A (ja) * 2010-11-16 2013-11-28 ポジ ヴィジョナリー ソリューションズ リミテッド ライアビリティ パートナーシップ 腸運動調節剤、ガス滞留防止剤及び消化酵素を含む過敏性腸症候群の治療のための経口投与用医薬組成物及びその調製方法

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4770593A (en) * 1992-07-07 1994-01-31 Sepracor, Inc. Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
AU4666393A (en) * 1992-07-07 1994-01-31 Sepracor, Inc. Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
US5712293A (en) * 1995-06-07 1998-01-27 Sepracor, Inc. Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
US6126970A (en) * 1995-12-01 2000-10-03 Janssen Pharmaceutica N.V. Cisapride sustained release
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
EP0803251B1 (fr) * 1996-04-23 2002-07-17 Janssen Pharmaceutica N.V. Formes solides d'administration de cisapride à libération immédiate et indépendente du PH
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
US5739151A (en) * 1996-07-19 1998-04-14 Sepracor Inc. Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride
US6147093A (en) 1996-07-19 2000-11-14 Sepracor Inc. Methods for treating gastroesophageal reflux disease
AU7919398A (en) * 1997-06-11 1998-12-30 Janssen Pharmaceutica N.V. Immediate release ph-independent solid dosage form of (+)- or (-)-cisapride
IT1298269B1 (it) * 1998-02-18 1999-12-20 Promefarm S R L Uso di un polietilenglicole come mezzo di contrasto in ecografia
ES2237117T3 (es) 1998-06-15 2005-07-16 Sepracor Inc. Uso de (-)norcisaprida opticamente pura en el tratamiento del sindrome del intestino irritable.
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6676933B2 (en) 2001-05-23 2004-01-13 Osmotica Corp. Pharmaceutical composition containing mosapride and pancreatin
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions
ZA200606409B (en) * 2004-01-06 2008-06-25 Panacea Biotec Ltd Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic
CO5790164A1 (es) * 2006-08-10 2007-08-31 Procaps S A Composicion farmaceutica solida que incluye en combinacion un agente regulador de la motilidad intestinal y un agente antiflatulento
MX2010012480A (es) * 2010-11-16 2012-05-16 Posi Visionary Solutions Llp Composicion farmaceutica adaptada para administrarse oralmente y proceso para su preparación para su prevencion y tratamiento, del sindrome del intestino irritable, a base de un odificador dela motalidad intestinal y a-d- galactosidasa.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013542985A (ja) * 2010-11-16 2013-11-28 ポジ ヴィジョナリー ソリューションズ リミテッド ライアビリティ パートナーシップ 腸運動調節剤、ガス滞留防止剤及び消化酵素を含む過敏性腸症候群の治療のための経口投与用医薬組成物及びその調製方法
JP2016179995A (ja) * 2010-11-16 2016-10-13 ポジ ヴィジョナリー ソリューションズ リミテッド ライアビリティ パートナーシップ 腸運動調節剤、ガス滞留防止剤及び消化酵素を含む過敏性腸症候群の治療のための経口投与用医薬組成物及びその調製方法

Also Published As

Publication number Publication date
AU7397194A (en) 1995-02-06
EP0707492A1 (fr) 1996-04-24
WO1995001803A1 (fr) 1995-01-19
CA2166730A1 (fr) 1995-01-19

Similar Documents

Publication Publication Date Title
JPH08512322A (ja) Ｈ▲下２▼拮抗剤−胃腸運動性の薬剤組合せ物
KR100292124B1 (ko) 온단세트론을포함하는경구조성물
US20040234593A1 (en) Diphenhydramine tannate compositions and methods of use
CZ154997A3 (en) Lyophilized preparation for oral administration
EP0550083B1 (fr) Médicaments pour le traitement de conditions inflammatoires ou pour l'analgésie contenants un NSAID et du citrate de bismuth-ranitidine
EP0533281B1 (fr) Utilisation de ranitidine bismuth citrate en combinaison avec claritromycin ou claritromycin et tetracycline, pour la fabrication d'un médicament pour le traitement des maladies gastrointestinales
KR0149029B1 (ko) 지사제 조성물
US8748489B2 (en) Solid pharmaceutical composition containing a combination of an intestinal motility regulating agent and an antiflatulent
US4766117A (en) Antiinflammatory compositions and methods
JPH08512321A (ja) Ｈ▲下２▼拮抗剤−アルギネート−制酸剤の組合せ物
US20050038018A1 (en) Meloxicam compositions
WO1995001780A1 (fr) Combinaisons alginate-antagoniste de h¿2?
US20060269598A1 (en) Antihistaminic/Decongestant/Anticholinergic Compositions and Methods of Use
WO1995001792A1 (fr) Composes anti-h2-antihistaminiques
WO1995016446A1 (fr) Composes a base de ranitidine
AU2003217704A1 (en) Diphenhydramine tannate compositions and methods of use
US4874757A (en) Antinflammatory compositions and methods
US20060269597A1 (en) Tannate Compositions and Methods of Use for the Treatment of Respiratory Tract Conditions
WO1995001784A1 (fr) Composes anti-flatulences a base d'antagoniste d'h2 et de sucralfate
WO1996008238A1 (fr) Utilisation d'agents d'accroissement paracellulaires tels que le glucose pour accroitre l'absorption d'antagonistes du recepteur h2 de l'histamine
US4812455A (en) Antiinflammatory compositions and methods
AU690664B2 (en) Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion
AU677108B2 (en) Ranitidine and calcium carbonate pharmaceutical combination product
JP2003226652A (ja) ヘリコバクター・ピロリ菌毒性抑制剤
MXPA96004553A (en) Compositions of dosing ranitidine b